The overall objective of the study is to investigate the effects of five weeks of heat-suit training on training-associated changes in hemoglobin mass, skeletal muscle characteristics and endurance exercise performance in elite cyclists
Endurance exercise performance depends on a range of determinants, including hemoglobin mass in blood and content of respiratory mitochondria in skeletal muscle. Low-intensity training (LIT) with heat exposure may be beneficial for development of these variables. The purpose of this study is to investigate the effects of five weeks of LIT-training with heat suit (five times a week; 50 min per session) on hemoglobin mass and other blood characteristics in elite cyclists (males and females) compared to a non-heat-suit training control group, including subsequent investigation of the retrograde effects of \~one month of training without heat suit. The study will also investigate the effects of heat-suit training on endurance exercise performance/performance determinants and other muscle biological charateristics, and will investigate the basic characteristics of mitochondrial function and abundances in these highly trained athletes. Training sessions with heat suit (or lack thereof) will complement the habitual training routines of the participants.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
53
Participants (elite cyclists) will conduct five 50-minute low-intensity cycling sessions with heat suit per week for five weeks. These sessions will complement their habitual training routines, which will consist of endurance training with intensities at or below lactate threshold. Participants will ingest 100 mg Fe2+ on a daily basis to support de novo synthesis of hemoglobin
Participants (elite cyclists) will conduct low-intensity cycling without heat suit for five weeks (volume- and intensity-matched to the heat-suit arm). Participants will ingest 100 mg Fe2+ on a daily basis to support de novo synthesis of hemoglobin
Inland Norway University of Applied Sciences
Lillehammer, Inland Norway, Norway
Hemoglobin mass
Hemoglobin mass measured using CO rebreathing (g)
Time frame: Changes from before the intervention (T0) to immediately after the intervention (T1)
Maximal oxygen consumption
Maximal oxygen consumption measured during an incremental cycling exercise test to exhaustion
Time frame: Changes from before the intervention (T0) to immediately after the intervention (T1)
Maximal aerobic power output
Maximal aerobic power output measured as mean power output during the last minute of an incremental cycling exercise test to exhaustion
Time frame: Changes from before the intervention (T0) to immediately after the intervention (T1)
Power output at lactate threshold
Power output at 4 mmol blood lactate concentration measured during an incremental cycling exercise test (with 5 minute steps)
Time frame: Changes from before the intervention (T0) to immediately after the intervention (T1)
Gross efficiency
Contribution of total energy turnover to power output in the fresh and fatigued state
Time frame: Changes from before the intervention (T0) to immediately after the intervention (T1)
Fractional utilization of VO2max (incremental test)
Fractional utilization of VO2max measured at 4 mmol blood lactate concentrations measured during an incremental cycling exercise test (with 5 minute steps)
Time frame: Changes from before the intervention (T0) to immediately after the intervention (T1)
Fractional utilization of VO2max (15-minute performance test)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Fractional utilization of VO2max measured during a 15-minute performance test
Time frame: Changes from before the intervention (T0) to immediately after the intervention (T1)
Sprint performance
Mean power output measured during a 10-second all-out cycling sprint
Time frame: Changes from before the intervention (T0) to immediately after the intervention (T1)
Performance during a 15-minute all-out cycling test
Mean power output measured during a 15-minute all-out cycling test
Time frame: Changes from before the intervention (T0) to immediately after the intervention (T1)
Performance during a 40-minute all-out cycling test
Mean power output measured during a 40-minute all-out cycling test
Time frame: Changes from before the intervention (T0) to immediately after the intervention (T1)
Maximal concentric force production
Maximal concentric force production measured using a seated leg press test
Time frame: Changes from before the intervention (T0) to immediately after the intervention (T1)
Gene expression in skeletal muscle
RNA abundances in m. vastus lateralis measured using qPCR (e.g. messenger RNA and ribosomal RNA)
Time frame: Changes from before the intervention (T0) to immediately after the intervention (T1)
Mitochondrial respiration in skeletal muscle
The ability of muscle mitochondria (extracted from homogenate; m. vastus lateralis) to consume oxygen in vitro
Time frame: Immediately after the intervention (T1)
Mitochondrial content in skeletal muscle
Mitochondria content in m. vastus lateralis measured using electron microscopy
Time frame: Immediately after the intervention (T1)
Total RNA content in skeletal muscle
Total RNA content in m. vastus lateralis (per unit tissue weight) measured using spectrophotometry
Time frame: Changes from before the intervention (T0) to immediately after the intervention (T1)
Blood volume
Blood volume measured using CO rebreathing
Time frame: Changes from before the intervention (T0) to immediately after the intervention (T1)
Plasma volume
Plasma volume measured using CO rebreathing
Time frame: Changes from before the intervention (T0) to immediately after the intervention (T1)
Red blood cell volume
Red blood cell volume measured using CO rebreathing
Time frame: Changes from before the intervention (T0) to immediately after the intervention (T1)
Hematocrit
Hematocrit measured using centrifugation
Time frame: Changes from before the intervention (T0) to immediately after the intervention (T1)
Hemoglobin mass
Hemoglobin mass measured using CO rebreathing (g)
Time frame: Changes from immediately after the intervention (T1) to one month after the intervention (T2)
Blood volume
Blood volume measured using CO rebreathing
Time frame: Changes from immediately after the intervention (T1) to one month after the intervention (T2)
Plasma volume
Plasma volume measured using CO rebreathing
Time frame: Changes from immediately after the intervention (T1) to one month after the intervention (T2)
Red blood cell volume
Red blood cell volume measured using CO rebreathing
Time frame: Changes from immediately after the intervention (T1) to one month after the intervention (T2)
Hematocrit
Hematocrit measured using centrifugation
Time frame: Changes from immediately after the intervention (T1) to one month after the intervention (T2)